Title
Amendment to R.A. 3720 on Food, Drugs, Devices, Cosmetics
Law
Executive Order No. 175
Decision Date
May 22, 1987
Corazon C. Aquino's Executive Order No. 175 amends Republic Act No. 3720 to enhance the regulatory framework for ensuring the safety, purity, and efficacy of foods, drugs, and cosmetics, while establishing the Bureau of Food and Drugs as the authority responsible for enforcement and compliance.
A

Declaration of Policies

  • The State shall protect and promote the right to health of the people and instill health consciousness.
  • The State shall establish an effective food and drug regulatory system and promote health manpower development and research.

Government Responsibilities in Implementation

  • The Department of Health shall set standards and adopt measures for the purity and safety of foods, cosmetics, drugs, and devices.
  • Measures include banning, recalling, or withdrawing unregistered, unsafe, inefficacious, or therapeutically doubtful drugs and devices.
  • Establishment of an official National Drug Formulary and use of generic names on labels.
  • Strengthening the Bureau of Food and Drugs.

Definitions

  • "Bureau": Refers to the Bureau of Food and Drugs.
  • "Drugs": Includes articles recognized in official pharmacopeias and those intended for diagnosis, cure, mitigation, treatment, prevention of disease, or to affect body structure/function, excluding devices.
  • "New Drugs": Any drug not generally recognized by qualified experts for safety, efficacy, and quality; includes drugs with new active ingredients, combinations, indications, administration modes, or dosages.
  • Additional definitions added include batch, batch number, director, distribute, expiry date, export, import, manufacture, and new veterinary drugs.

Prohibited Acts

  • Manufacturing, importing, exporting, selling, distributing adulterated or misbranded food, drugs, devices, or cosmetics.
  • Adulteration or misbranding itself.
  • Preventing authorized inspection or sample collection.
  • False guaranties or undertakings.
  • Forgery or unauthorized use of identification devices.
  • Disclosure of protected trade secrets except as authorized.
  • Alteration or mutilation of labeling causing adulteration or misbranding.
  • Misuse of regulatory claims in labeling or advertising.
  • Manufacturing, selling, distributing unregistered or unlicensed drugs or devices.
  • Sale of expired drugs or devices and release without batch certification when required.

Penalties

  • Violations carry imprisonment from 1 to 5 years or fines from Php 5,000 to Php 10,000, or both.
  • Corporate officers and responsible partners may be held liable.
  • Good faith purchase or possession may provide defenses if cooperation is given.

Adulteration of Drugs or Devices

  • Occurs if contaminated, filthy, prepared under unsanitary conditions, contains poisonous containers, or unauthorized coloring.
  • Failing to meet official compendium standards unless deviations are approved and labeled.
  • Presence of substituted substances or ineffective manufacturing practices.

Misbranding of Drugs or Devices

  • False or misleading labeling.
  • Missing required label information such as manufacturer, quantity, or conspicuousness of required statements.
  • Failure to disclose habit-forming or controlled substances with warnings.
  • Incorrect or absent ingredient listings.
  • Missing direc... (truncated, full summary follows)

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.